ARTICLE | Company News
Celltech Group, Pharmacia deal
March 12, 2001 8:00 AM UTC
The companies will co-develop and co-promote worldwide CCH's CDP 870 TNF-alpha humanized antibody fragment to treat rheumatoid arthritis (RA) and Crohn's disease. PHA will pay $50 million upfront to ...